由JUN诱导的超强增强器RNA形成R循环,促进鼻癌转移
Qunying Jia1, Yuan Tan1, Yuejin Li1
1Hunan Key Laboratory of Oncotarget Gene and Clinical Laboratory, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, 410013, Changsha, China.
Cell death & disease
|July 21, 2023
概括
一种新的超级增强器RNA (seRNA) 通过形成R循环和调节NDRG1.1.等基因来促进鼻癌 (NPC) 转移. 这种seRNA是NPC患者潜在的预后因素.
科学领域:
- 分子瘤学分子瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 超级增强剂 (SE) 驱动瘤基因表达,并产生增强剂RNA (eRNA/seRNA),对癌症进展至关重要.
- 鼻癌 (NPC) 转移是一个复杂的过程,受异常基因调节的影响.
研究的目的:
- 识别和表征一种参与NPC转移的新型seRNA.
- 阐明这种seRNA调节目标基因并促进转移的机制.
- 为了评估在NPC患者中识别的seRNA的预后意义.
主要方法:
- 全球运行测序,ChIP测序和RNA测序用于选转移相关的seRNAs.
- 进行了体外和体内功能测试,以评估已识别的seRNA在NPC细胞转移中的作用.
- 机理学研究研究了R循环形成,蛋白相互作用和染色质循环.
主要成果:
- 一种特定的seRNA,seRNA-NPCM,被确定并发现在NPC组织和转移性细胞系中升高.
- JUN转录因子调节了seRNA-NPCM的表达.
- seRNA-NPCM通过形成R循环,招募hnnRNPR和促进染色质循环来激活NDRG1和TRIB1转录来促进NPC细胞转移.
- seRNA-NPCM和NDRG1是NPC患者的独立预后因素.
结论:
- 由JUN介导的seRNA-NPCM是NPC转移的关键驱动因素,通过R循环形成和NDRG1和TRIB1.1的转录调节.
- seRNA-NPCM代表了一个潜在的治疗标,也是鼻癌的宝贵预后生物标志物.
相关概念视频
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

